Many companies like to claim that they have revolutionary, game-changing products. Few live up to the hype.
Novocure (NASDAQ: NVCR) could be an exception. Its tumor-treating fields (TTFields) therapy uses electrical signals to disrupt the division of tumor cells.
But just because a company has a potentially game-changing product doesn't mean that its stock is necessarily a great pick. There are other factors to consider. Is Novocure stock a buy right now? Here are the bull and bear cases.
Source Fool.com